Ticker	Volume	Price	Price Delta
DJIA	12,580.70	+125.86	1.01%
S&P 500	1,332.42	+14.60	1.11%
Nasdaq	2,870.99	+33.46	1.18%

Ticker	Volume	Price	Price Delta
STOXX 50	2,160.31	+12.39	0.58%
FTSE 100	5,391.14	+34.80	0.65%
DAX	6,396.84	+73.65	1.16%

Ticker	Volume	Price	Price Delta
Nikkei	8,633.19	-23.89	-0.28%
TOPIX	723.62	-3.41	-0.47%
Hang Seng	18,737.10	-318.40	-1.67%

Gold

1,552.20

+0.08%

EUR-USD

1.2480

-0.1847%

Nasdaq

2,870.99

+1.18%

DJIA

12,580.70

+1.01%

S&P 500

1,332.42

+1.11%

FTSE 100

5,391.14

+0.65%

STOXX 50

2,160.31

+0.58%

DAX

6,396.84

+1.16%

Oil (WTI)

90.33

-0.47%

U.S. 10-year

1.719%

-0.026

BAC:US

7.44

+4.06%

FB:US

28.84

-9.62%

Bloomberg

Exchange: -
Sector: Consumer, Non-cyclical
Industry: Commercial Services
Sub-Industry: Research&Development

Pharmaceutical Product Development Inc

PPDI:US

Acquired

As of 12/05/2011.

Pharmaceutical Product Development Inc (PPDI:US) was acquired

Company Profile

Pharmaceutical Product Development, Inc. offers drug discovery and development services to pharmaceutical, biotechnology, and medical device companies. The Company conducts pre-clinical programs and phase I to phase IV clinical trials. PPD provides product launch services, and patient compliance and medical communications programs.